Investigational Meningococcal Vaccine Study

Now Enrolling Children 10-17

Now Enrolling

About this research study

Neisseria meningitidis can cause serious meningococcal disease, including brain and spinal cord infection (meningitis). Even in healthy individuals, invasive meningococcal disease can rapidly lead to severe illness, and sometimes death. Velocity is conducting a research study for an investigational meningococcal vaccine.

Eligible participants...

  • Must be age 10 to 17
  • Must NOT have received any vaccines within the past 4 weeks
  • Must NOT have received vaccination against meningococcal B

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Albuquerque, New Mexico • Velocity Clinical Research

3901 Carlisle Blvd NE, Albuquerque, NM 87107
Phone: (505) 243-1627

Omaha, Nebraska • Velocity Clinical Research

3319 N. 107th St., Omaha, NE 68134
Phone: (513) 381-3320

Washington, District of Columbia • Velocity Clinical Research

4910 Massachusetts Ave NW, Ste 315, Washington, DC 20016
Phone: (202) 998-3833
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy